LEADER 04422nam 22007575 450 001 9910779721603321 005 20230802010507.0 010 $a3-11-026622-9 024 7 $a10.1515/9783110266221 035 $a(CKB)2550000001096716 035 $a(EBL)893849 035 $a(OCoLC)829462208 035 $a(SSID)ssj0000873451 035 $a(PQKBManifestationID)11536713 035 $a(PQKBTitleCode)TC0000873451 035 $a(PQKBWorkID)10877609 035 $a(PQKB)10009295 035 $a(DE-B1597)173424 035 $a(OCoLC)1013963497 035 $a(OCoLC)853259053 035 $a(DE-B1597)9783110266221 035 $a(MiAaPQ)EBC893849 035 $a(EXLCZ)992550000001096716 100 $a20191221d2012 fg 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aEndogenous Interferences in Clinical Laboratory Tests $eIcteric, Lipemic and Turbid Samples /$fMartin H. Kroll, Christopher R. McCudden 210 1$aBerlin ;$aBoston :$cDe Gruyter,$d[2012] 210 4$dİ2012 215 $a1 online resource (155 p.) 225 0 $aPatient Safety ;$v5 300 $aDescription based upon print version of record. 311 $a3-11-026620-2 311 $a1-299-71999-6 327 $tFrontmatter --$tPreface --$tContents --$t1 Accuracy Goals for Laboratory Tests --$t2 Nature of Interferences --$t3 The Nature of Icteric Interference --$t4 The Nature of Lipemic and Turbidity Interferences --$t5 Measurement of Interference --$t6 Origin of Icteric Samples --$t7 Impact of Icterus --$t8 Origin of Lipemia and Turbidity --$t9 Impact of Lipemia/Turbidity --$t10 Endogenous Interferences in Clinical Laboratory Tests: Icteric, Lipemic and Turbid Samples --$t11 Reporting of Results --$t12 Analyte-dependent Interference --$tIndex 330 $aThe goal of clinical laboratories is to produce accurate information for clinical decision making in medicine. More than half of the medical decisions made depend on clinical laboratory tests. Patient safety represents an important and critical problem for laboratories. They need to assure that the information they deliver to physicians is accurate, and therefore safe for clinicians to use. Endogenous compounds can interfere with laboratory tests, decreasing accuracy and threatening patient safety. Elevated bilirubin (bilirubinemia) and elevated lipids (lipemia) are common conditions that cause significant interferences with laboratory results. Clinicians depend on laboratories to detect these endogenous interferences. Laboratories must have a means to detect these endogenous interferences, make decisions about reporting results, and evaluate their impact. Most clinical pathology books provide only an abbreviated introduction to the subject, or provide a long list of references, without the necessary foundation for evaluating their significance. Package inserts typically provide scant information. This book provides the empirical and theoretical foundation for these interferences, describes the clinical settings where they occur, and explains their evaluation and detection, allowing the laboratory to interpret the available data on interferences and make the appropriate decision to effectively report test results while protecting patient safety. 410 0$aPatient Safety 606 $aClinical Chemistry Tests$xmethods 606 $aSpecimen Handling 606 $aBilirubin$xisolation & purification 606 $aLipids$xisolation & pruification 606 $aReproducibility of Results 606 $aPatient Safety 610 $aBilirubinemia. 610 $aClinical Pathology. 610 $aInterference. 610 $aLipemia. 610 $aPatient Safety. 615 12$aClinical Chemistry Tests$xmethods. 615 22$aSpecimen Handling. 615 22$aBilirubin$xisolation & purification. 615 22$aLipids$xisolation & pruification. 615 22$aReproducibility of Results. 615 22$aPatient Safety. 676 $a616.0756 700 $aKroll$b Martin H.$4aut$4http://id.loc.gov/vocabulary/relators/aut.$01468975 702 $aMcCudden$b Christopher R.$4aut$4http://id.loc.gov/vocabulary/relators/aut. 801 0$bDE-B1597 801 1$bDE-B1597 906 $aBOOK 912 $a9910779721603321 996 $aEndogenous Interferences in Clinical Laboratory Tests$93680375 997 $aUNINA LEADER 01605nam0 2200373 i 450 001 VAN00126143 005 20250122025306.984 017 70$2N$a9783030055752 100 $a20200113d2019 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 181 $ai$b e 182 $ab 200 1 $aPharmacology and Applications of Naturally Occurring Iridoids$fBiswanath Dinda 210 $aCham$cSpringer$d2019 215 $aXXVIII, 296 p.$cill.$d24 cm 620 $aCH$dCham$3VANL001889 676 $a540$cChimica generale$v22 676 $a547$cChimica organica$v22 676 $a615.1$cFarmacologia. Farmaci. Farmacia$v22 676 $a615.19$cChimica farmaceutica. Tecnologia farmaceutica. Chimica medica$v22 676 $a615.9$cTossicologia$v22 676 $a543$cChimica analitica$v22 700 1$aDinda$bBiswanath$3VANV095267$0767390 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20250124$gRICA 856 4 $uhttps://link.springer.com/book/10.1007/978-3-030-05575-2$zE-book - Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$1IT-CE0101$2VAN17 912 $fN 912 $aVAN00126143 950 $aBIBLIOTECA DEL DIPARTIMENTO DI SCIENZE E TECNOLOGIE AMBIENTALI BIOLOGICHE E FARMACEUTICHE$d17CONS e-book 2113 $e17BIB2113/98 98 20200113 996 $aPharmacology and Applications of Naturally Occurring Iridoids$91570918 997 $aUNICAMPANIA